• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载光敏剂脂质体的光动力疗法,其光敏剂具有聚集诱导发光。

Photodynamic Therapy with Liposomes Encapsulating Photosensitizers with Aggregation-Induced Emission.

机构信息

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.

Beijing National Laboratory for Molecular Sciences (BNLMS), Key Laboratory of Colloid and Interface Science , Institute of Chemistry, Chinese Academy of Sciences , Beijing 100190 , China.

出版信息

Nano Lett. 2019 Mar 13;19(3):1821-1826. doi: 10.1021/acs.nanolett.8b04875. Epub 2019 Feb 19.

DOI:10.1021/acs.nanolett.8b04875
PMID:30768274
Abstract

As a noninvasive treatment, photodynamic therapy (PDT) is a promising strategy against tumors. It is based on photosensitizer (PS)-induced phototoxicity after irradiation. However, most clinically approved PSs will be widely distributed in normal tissues, especially in the skin, where they will induce phototoxicity on exposure to light. Therefore, patients must remain in a dark room for up to several weeks during or after a PDT. Herein, we proposed a strategy of aggregation-induced emission PSs (AIE-PSs) entrapped in liposomes with controlled photosensitization. The AIE-PSs begin to lose their photosensitivity when entrapped in liposomes. After liposomes have carried AIE-PSs into tumor tissues, the AIE-PSs will be released and immediately reaggregate in a targeted area as the liposomes are decomposed. Their photosensitivity can be triggered at turn-on state and induce cytotoxicity. Two different types of AIE molecules were synthesized and entrapped by liposomes, respectively, to verify the PDT features against tumors in vitro and in vivo. The results indicate that, using this strategy, the photosensitivity of AIE-PS can be controlled and PDT can be treated under normal working conditions, not necessarily in a dark room.

摘要

作为一种非侵入性的治疗方法,光动力疗法(PDT)是一种有前途的肿瘤治疗策略。它基于光敏剂(PS)在照射后诱导的光毒性。然而,大多数临床批准的 PS 会广泛分布在正常组织中,特别是在皮肤中,在那里它们会在暴露于光时引起光毒性。因此,患者在 PDT 期间或之后必须在暗室中呆上长达数周。在这里,我们提出了一种将聚集诱导发射 PS(AIE-PS)包封在脂质体中的策略,以控制光敏化作用。AIE-PS 在包封在脂质体中时开始失去其光敏性。当脂质体将 AIE-PS 携带到肿瘤组织中后,AIE-PS 将被释放并立即在靶向区域重新聚集,因为脂质体被分解。它们的光敏性可以在开启状态下被触发,并诱导细胞毒性。两种不同类型的 AIE 分子分别被脂质体包封,以验证体外和体内对肿瘤的 PDT 特征。结果表明,通过这种策略,可以控制 AIE-PS 的光敏性,并可以在正常工作条件下进行 PDT 治疗,而不一定在暗室中进行。

相似文献

1
Photodynamic Therapy with Liposomes Encapsulating Photosensitizers with Aggregation-Induced Emission.载光敏剂脂质体的光动力疗法,其光敏剂具有聚集诱导发光。
Nano Lett. 2019 Mar 13;19(3):1821-1826. doi: 10.1021/acs.nanolett.8b04875. Epub 2019 Feb 19.
2
AIE material for photodynamic therapy.用于光动力疗法的 AIE 材料。
Prog Mol Biol Transl Sci. 2021;185:45-73. doi: 10.1016/bs.pmbts.2021.06.010. Epub 2021 Jul 16.
3
Progress and trends of photodynamic therapy: From traditional photosensitizers to AIE-based photosensitizers.光动力疗法的进展与趋势:从传统光敏剂到基于聚集诱导发光的光敏剂。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102254. doi: 10.1016/j.pdpdt.2021.102254. Epub 2021 Mar 10.
4
Photosensitizers with Aggregation-Induced Emission: Materials and Biomedical Applications.具有聚集诱导发光特性的光敏剂:材料与生物医学应用。
Adv Mater. 2018 Nov;30(45):e1801350. doi: 10.1002/adma.201801350. Epub 2018 Jul 31.
5
Recent Advances in Hypoxia-Overcoming Strategy of Aggregation-Induced Emission Photosensitizers for Efficient Photodynamic Therapy.聚集诱导发光型光敏剂克服乏氧策略用于高效光动力治疗的研究进展。
Adv Healthc Mater. 2021 Dec;10(24):e2101607. doi: 10.1002/adhm.202101607. Epub 2021 Oct 27.
6
Aggregation-Induced Emission (AIE) Polymeric Micelles for Imaging-Guided Photodynamic Cancer Therapy.用于成像引导光动力癌症治疗的聚集诱导发光(AIE)聚合物胶束
Nanomaterials (Basel). 2018 Nov 7;8(11):921. doi: 10.3390/nano8110921.
7
Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical.基于聚集诱导发光光敏剂的光动力疗法治疗癌症:从化学到临床。
J Nanobiotechnology. 2022 Jul 26;20(1):344. doi: 10.1186/s12951-022-01553-z.
8
Recent molecular design strategies for efficient photodynamic therapy and its synergistic therapy based on AIE photosensitizers.基于聚集诱导发光光敏剂的高效光动力治疗及其协同治疗的最新分子设计策略。
Eur J Med Chem. 2022 Dec 15;244:114843. doi: 10.1016/j.ejmech.2022.114843. Epub 2022 Oct 14.
9
Microneedle Device Delivering Aggregation-Induced Emission Photosensitizers for Enhanced Metronomic Photodynamic Therapy of Cancer.用于增强癌症节律性光动力疗法的递送聚集诱导发光光敏剂的微针装置
ACS Appl Mater Interfaces. 2023 Apr 5;15(13):16526-16538. doi: 10.1021/acsami.3c01682. Epub 2023 Mar 26.
10
Reviewing the evolutive ACQ-to-AIE transformation of photosensitizers for phototheranostics.回顾用于光诊疗的光敏剂从ACQ到AIE的演变转化。
Luminescence. 2023 Dec 26. doi: 10.1002/bio.4655.

引用本文的文献

1
Application of aggregation-induced emission materials in gastrointestinal diseases.聚集诱导发光材料在胃肠道疾病中的应用。
World J Gastroenterol. 2025 Apr 28;31(16):105378. doi: 10.3748/wjg.v31.i16.105378.
2
Engineering photodynamics for treatment, priming and imaging.用于治疗、启动和成像的工程光动力学。
Nat Rev Bioeng. 2024 Sep;2(9):752-769. doi: 10.1038/s44222-024-00196-z. Epub 2024 Jun 19.
3
Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.纳米脂质体介导的肝癌光热治疗的临床前进展
Lipids Health Dis. 2025 Jan 31;24(1):31. doi: 10.1186/s12944-024-02429-x.
4
Innovative Approaches to Enhancing the Biomedical Properties of Liposomes.增强脂质体生物医学特性的创新方法。
Pharmaceutics. 2024 Nov 27;16(12):1525. doi: 10.3390/pharmaceutics16121525.
5
Molecular engineering of AIE-active boron clustoluminogens for enhanced boron neutron capture therapy.用于增强硼中子俘获疗法的具有聚集诱导发光活性的硼簇发光体的分子工程
Chem Sci. 2024 Feb 1;15(11):4019-4030. doi: 10.1039/d3sc06222h. eCollection 2024 Mar 13.
6
FAP Targeting of Photosensitizer-Loaded Polymersomes for Increased Light-Activated Cell Killing.载光敏剂聚合物囊泡的 FAP 靶向作用以增强光激活细胞杀伤。
Biomacromolecules. 2024 Feb 12;25(2):754-766. doi: 10.1021/acs.biomac.3c00943. Epub 2024 Jan 24.
7
Novel Tripodal Polyamine Tris-Pyrene: DNA/RNA Binding and Photodynamic Antiproliferative Activity.新型三脚架多胺三芘:DNA/RNA结合及光动力抗增殖活性
Pharmaceutics. 2023 Aug 25;15(9):2197. doi: 10.3390/pharmaceutics15092197.
8
Quatsomes Loaded with Squaraine Dye as an Effective Photosensitizer for Photodynamic Therapy.负载方酸菁染料的脂质体作为光动力疗法的有效光敏剂
Pharmaceutics. 2023 Mar 10;15(3):902. doi: 10.3390/pharmaceutics15030902.
9
A Sulfur-Bridging Sulfonate-Modified Zinc(II) Phthalocyanine Nanoliposome Possessing Hybrid Type I and Type II Photoreactions with Efficient Photodynamic Anticancer Effects.一种含硫桥联磺酸盐修饰的锌(II)酞菁纳米脂质体,具有高效光动力抗癌作用的混合 I 型和 II 型光反应。
Molecules. 2023 Feb 28;28(5):2250. doi: 10.3390/molecules28052250.
10
PpIX/IR-820 Dual-Modal Therapeutic Agents for Enhanced PDT/PTT Synergistic Therapy in Cervical Cancer.用于增强宫颈癌光动力疗法/光热疗法协同治疗的 PpIX/IR-820 双模态治疗剂
ACS Omega. 2022 Sep 15;7(49):44643-44656. doi: 10.1021/acsomega.2c02977. eCollection 2022 Dec 13.